chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 4.0
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: 6 d after DTaP given, patient recovered 5 am large induration with localized redness @ injection site.
Age: 1.7
Sex: F
Vaccine: DTAP, HIBV
Symptoms: Convulsion, Pyrexia
Clinical narrative: Fever began a few hours after vaccine. Had a seizure about 36 hrs after vaccine.
Age: 6.0
Sex: F
Vaccine: FLUN3
Symptoms: Accidental exposure
Clinical narrative: A spontaneous non-serious report of FLUMIST squirted into a child's eye has been received from the patient's mother who is a nurse concerning a 6 year old female patient. No medical history or concomitant medications were reported. On 24-Nov-2008, the patient received FLUMIST in the pediatrician's office. During administration, the patient moved and FLUMIST was squirted into the child's eye. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.
Age: 9.0
Sex: F
Vaccine: HEPA, PPV
Symptoms: Psychomotor hyperactivity, Urticaria
Clinical narrative: Hive broke out on her body - Hyperactive and playing.
Age: 0.2
Sex: F
Vaccine: PPV
Symptoms: Eye burns, Respiratory disorder
Clinical narrative: Respiratory alway clearing her nose, in the hot weather she get sexual acting. Can learn but do it very slow. Shrinking eyes.
Age: 2.0
Sex: M
Vaccine: PPV, RVX
Symptoms: Bowel movement irregularity, Dyspnoea, Influenza like illness, Sexual dysfunction
Clinical narrative: Flu like symptoms every time. Folded bowel movement. Very hard for him to breath.
Sex: F
Vaccine: DTAPHEPBIP, FLUX, MMRV, PPV
Symptoms: Diarrhoea, Dyskinesia, Irritability, Trichotillomania, Vomiting
Clinical narrative: Vomiting, diarrhea, rocking back and forward. Skin flare up picky, pulling out the hair, very fusses. Needed BENADRYL.
Sex: F
Vaccine: DTAPHEPBIP, MMRV, PPV, RVX
Symptoms: Bowel movement irregularity, Diarrhoea, Hair texture abnormal, Skin irritation, Vomiting
Clinical narrative: Folded bowel movement, vomiting and diarrhea picky skin, dry up hair needed BENADRYL.
Age: 0.15
Sex: F
Vaccine: DTAPHEPBIP, FLUX, PPV, RVX
Symptoms: Alopecia, Autism, Influenza like illness, Irritability, Skin irritation
Clinical narrative: Flu like symptoms, picky skin, thinning of the hair, very fussy. Need BENADRYL.
Age: 1.0
Sex: M
Vaccine: DTAP, FLU3, HIBV, IPV, PNC, DTAP, FLU3, HIBV, IPV, PNC
Symptoms: Aspartate aminotransferase increased, Blood culture negative, Blood electrolytes normal, Blood product transfusion, Bronchiolitis
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 306745).  A one-year-old male patient received the following vaccinations on 20 February 2008: a third intramuscular injection of DAPTACEL (lot number C2800AA); a second intramuscular injection of FLUZONE No Preservative 2007-2008 ( lot number UT2459LB); a third subcutaneous injection of IPOL (lot number A0169-2); a third intramuscular injection of PREVNAR (Wyeth, lot number C45150); and a third intramuscular injection of PEDVAXHIB (Merck, lot number 0076U).  The following day, the patient fell at home and hit his head, and later presented to the emergency room with a fever.  The following day he presented to the emergency department again with fever (103.1) and upper respiratory infection symptoms including cough, post tussive emesis, and irritability.  It was noted that he had a sick sibling at home.  He was treated with intravenous antibiotics and antipyretics, and discharged to home.  The next day, on 23 February 2008, he was seen by his primary care physician with respiratory congestion, wheezing, and intercostal retractions.  He was admitted to the hospital at that time with additional symptoms of bronchiolitis, conjunctivitis, otitis media, irritability, and poor appetite.  He was initially treated with breathing treatments and intravenous antibiotics.  During the course of his hospitalization he developed a diffuse urticarial rash, inflamed conjunctiva, swelling of the hands and feet, peeling skin on the feet, and red lips.  His fever increased to 106 degrees, and on 28 February 2008 he was transferred to a higher level of care.  Laboratory testing at that time revealed the following:  CRP 273, WBC 26,000, platelets 718,000, SGOT 44; electrolytes and echocardiogram were within limits, and viral testing and blood cultures were negative.  Cardiology was consulted, and he was diagnosed with atypical Kawasaki's disease without evidence of cardiac lesions.  He was treated with intravenous immunoglobulins and aspirin, after which he improved and was discharged to home on 03 March 2008 with instructions to follow-up for serial echocardiograms.  The event was considered to be recovered.
Age: 1.0
Sex: M
Vaccine: DTAP, FLU3, HIBV, IPV, PNC, DTAP, FLU3, HIBV, IPV, PNC
Symptoms: C-reactive protein increased, Cheilitis, Conjunctivitis, Cough, Decreased appetite
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 306745).  A one-year-old male patient received the following vaccinations on 20 February 2008: a third intramuscular injection of DAPTACEL (lot number C2800AA); a second intramuscular injection of FLUZONE No Preservative 2007-2008 ( lot number UT2459LB); a third subcutaneous injection of IPOL (lot number A0169-2); a third intramuscular injection of PREVNAR (Wyeth, lot number C45150); and a third intramuscular injection of PEDVAXHIB (Merck, lot number 0076U).  The following day, the patient fell at home and hit his head, and later presented to the emergency room with a fever.  The following day he presented to the emergency department again with fever (103.1) and upper respiratory infection symptoms including cough, post tussive emesis, and irritability.  It was noted that he had a sick sibling at home.  He was treated with intravenous antibiotics and antipyretics, and discharged to home.  The next day, on 23 February 2008, he was seen by his primary care physician with respiratory congestion, wheezing, and intercostal retractions.  He was admitted to the hospital at that time with additional symptoms of bronchiolitis, conjunctivitis, otitis media, irritability, and poor appetite.  He was initially treated with breathing treatments and intravenous antibiotics.  During the course of his hospitalization he developed a diffuse urticarial rash, inflamed conjunctiva, swelling of the hands and feet, peeling skin on the feet, and red lips.  His fever increased to 106 degrees, and on 28 February 2008 he was transferred to a higher level of care.  Laboratory testing at that time revealed the following:  CRP 273, WBC 26,000, platelets 718,000, SGOT 44; electrolytes and echocardiogram were within limits, and viral testing and blood cultures were negative.  Cardiology was consulted, and he was diagnosed with atypical Kawasaki's disease without evidence of cardiac lesions.  He was treated with intravenous immunoglobulins and aspirin, after which he improved and was discharged to home on 03 March 2008 with instructions to follow-up for serial echocardiograms.  The event was considered to be recovered.
Age: 1.0
Sex: M
Vaccine: DTAP, FLU3, HIBV, IPV, PNC, DTAP, FLU3, HIBV, IPV, PNC
Symptoms: Echocardiogram normal, Fall, Head injury, Irritability, Kawasaki's disease
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 306745).  A one-year-old male patient received the following vaccinations on 20 February 2008: a third intramuscular injection of DAPTACEL (lot number C2800AA); a second intramuscular injection of FLUZONE No Preservative 2007-2008 ( lot number UT2459LB); a third subcutaneous injection of IPOL (lot number A0169-2); a third intramuscular injection of PREVNAR (Wyeth, lot number C45150); and a third intramuscular injection of PEDVAXHIB (Merck, lot number 0076U).  The following day, the patient fell at home and hit his head, and later presented to the emergency room with a fever.  The following day he presented to the emergency department again with fever (103.1) and upper respiratory infection symptoms including cough, post tussive emesis, and irritability.  It was noted that he had a sick sibling at home.  He was treated with intravenous antibiotics and antipyretics, and discharged to home.  The next day, on 23 February 2008, he was seen by his primary care physician with respiratory congestion, wheezing, and intercostal retractions.  He was admitted to the hospital at that time with additional symptoms of bronchiolitis, conjunctivitis, otitis media, irritability, and poor appetite.  He was initially treated with breathing treatments and intravenous antibiotics.  During the course of his hospitalization he developed a diffuse urticarial rash, inflamed conjunctiva, swelling of the hands and feet, peeling skin on the feet, and red lips.  His fever increased to 106 degrees, and on 28 February 2008 he was transferred to a higher level of care.  Laboratory testing at that time revealed the following:  CRP 273, WBC 26,000, platelets 718,000, SGOT 44; electrolytes and echocardiogram were within limits, and viral testing and blood cultures were negative.  Cardiology was consulted, and he was diagnosed with atypical Kawasaki's disease without evidence of cardiac lesions.  He was treated with intravenous immunoglobulins and aspirin, after which he improved and was discharged to home on 03 March 2008 with instructions to follow-up for serial echocardiograms.  The event was considered to be recovered.
Age: 1.0
Sex: M
Vaccine: DTAP, FLU3, HIBV, IPV, PNC, DTAP, FLU3, HIBV, IPV, PNC
Symptoms: Oedema peripheral, Otitis media, Platelet count increased, Post-tussive vomiting, Pyrexia
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 306745).  A one-year-old male patient received the following vaccinations on 20 February 2008: a third intramuscular injection of DAPTACEL (lot number C2800AA); a second intramuscular injection of FLUZONE No Preservative 2007-2008 ( lot number UT2459LB); a third subcutaneous injection of IPOL (lot number A0169-2); a third intramuscular injection of PREVNAR (Wyeth, lot number C45150); and a third intramuscular injection of PEDVAXHIB (Merck, lot number 0076U).  The following day, the patient fell at home and hit his head, and later presented to the emergency room with a fever.  The following day he presented to the emergency department again with fever (103.1) and upper respiratory infection symptoms including cough, post tussive emesis, and irritability.  It was noted that he had a sick sibling at home.  He was treated with intravenous antibiotics and antipyretics, and discharged to home.  The next day, on 23 February 2008, he was seen by his primary care physician with respiratory congestion, wheezing, and intercostal retractions.  He was admitted to the hospital at that time with additional symptoms of bronchiolitis, conjunctivitis, otitis media, irritability, and poor appetite.  He was initially treated with breathing treatments and intravenous antibiotics.  During the course of his hospitalization he developed a diffuse urticarial rash, inflamed conjunctiva, swelling of the hands and feet, peeling skin on the feet, and red lips.  His fever increased to 106 degrees, and on 28 February 2008 he was transferred to a higher level of care.  Laboratory testing at that time revealed the following:  CRP 273, WBC 26,000, platelets 718,000, SGOT 44; electrolytes and echocardiogram were within limits, and viral testing and blood cultures were negative.  Cardiology was consulted, and he was diagnosed with atypical Kawasaki's disease without evidence of cardiac lesions.  He was treated with intravenous immunoglobulins and aspirin, after which he improved and was discharged to home on 03 March 2008 with instructions to follow-up for serial echocardiograms.  The event was considered to be recovered.
Age: 1.0
Sex: M
Vaccine: DTAP, FLU3, HIBV, IPV, PNC, DTAP, FLU3, HIBV, IPV, PNC
Symptoms: Respiratory tract congestion, Sick relative, Skin exfoliation, Upper respiratory tract infection, Urticaria
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 306745).  A one-year-old male patient received the following vaccinations on 20 February 2008: a third intramuscular injection of DAPTACEL (lot number C2800AA); a second intramuscular injection of FLUZONE No Preservative 2007-2008 ( lot number UT2459LB); a third subcutaneous injection of IPOL (lot number A0169-2); a third intramuscular injection of PREVNAR (Wyeth, lot number C45150); and a third intramuscular injection of PEDVAXHIB (Merck, lot number 0076U).  The following day, the patient fell at home and hit his head, and later presented to the emergency room with a fever.  The following day he presented to the emergency department again with fever (103.1) and upper respiratory infection symptoms including cough, post tussive emesis, and irritability.  It was noted that he had a sick sibling at home.  He was treated with intravenous antibiotics and antipyretics, and discharged to home.  The next day, on 23 February 2008, he was seen by his primary care physician with respiratory congestion, wheezing, and intercostal retractions.  He was admitted to the hospital at that time with additional symptoms of bronchiolitis, conjunctivitis, otitis media, irritability, and poor appetite.  He was initially treated with breathing treatments and intravenous antibiotics.  During the course of his hospitalization he developed a diffuse urticarial rash, inflamed conjunctiva, swelling of the hands and feet, peeling skin on the feet, and red lips.  His fever increased to 106 degrees, and on 28 February 2008 he was transferred to a higher level of care.  Laboratory testing at that time revealed the following:  CRP 273, WBC 26,000, platelets 718,000, SGOT 44; electrolytes and echocardiogram were within limits, and viral testing and blood cultures were negative.  Cardiology was consulted, and he was diagnosed with atypical Kawasaki's disease without evidence of cardiac lesions.  He was treated with intravenous immunoglobulins and aspirin, after which he improved and was discharged to home on 03 March 2008 with instructions to follow-up for serial echocardiograms.  The event was considered to be recovered.
Age: 1.0
Sex: M
Vaccine: DTAP, FLU3, HIBV, IPV, PNC, DTAP, FLU3, HIBV, IPV, PNC
Symptoms: Use of accessory respiratory muscles, Viral test negative, Wheezing, White blood cell count increased
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 306745).  A one-year-old male patient received the following vaccinations on 20 February 2008: a third intramuscular injection of DAPTACEL (lot number C2800AA); a second intramuscular injection of FLUZONE No Preservative 2007-2008 ( lot number UT2459LB); a third subcutaneous injection of IPOL (lot number A0169-2); a third intramuscular injection of PREVNAR (Wyeth, lot number C45150); and a third intramuscular injection of PEDVAXHIB (Merck, lot number 0076U).  The following day, the patient fell at home and hit his head, and later presented to the emergency room with a fever.  The following day he presented to the emergency department again with fever (103.1) and upper respiratory infection symptoms including cough, post tussive emesis, and irritability.  It was noted that he had a sick sibling at home.  He was treated with intravenous antibiotics and antipyretics, and discharged to home.  The next day, on 23 February 2008, he was seen by his primary care physician with respiratory congestion, wheezing, and intercostal retractions.  He was admitted to the hospital at that time with additional symptoms of bronchiolitis, conjunctivitis, otitis media, irritability, and poor appetite.  He was initially treated with breathing treatments and intravenous antibiotics.  During the course of his hospitalization he developed a diffuse urticarial rash, inflamed conjunctiva, swelling of the hands and feet, peeling skin on the feet, and red lips.  His fever increased to 106 degrees, and on 28 February 2008 he was transferred to a higher level of care.  Laboratory testing at that time revealed the following:  CRP 273, WBC 26,000, platelets 718,000, SGOT 44; electrolytes and echocardiogram were within limits, and viral testing and blood cultures were negative.  Cardiology was consulted, and he was diagnosed with atypical Kawasaki's disease without evidence of cardiac lesions.  He was treated with intravenous immunoglobulins and aspirin, after which he improved and was discharged to home on 03 March 2008 with instructions to follow-up for serial echocardiograms.  The event was considered to be recovered.
Age: 1.0
Sex: M
Vaccine: DTAP, FLU3, HIBV, IPV, PNC, DTAP, FLU3, HIBV, IPV, PNC
Symptoms: Oedema peripheral, Otitis media, Platelet count increased, Pyrexia, Skin exfoliation
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 306745).  A one-year-old male patient received the following vaccinations on 20 February 2008: a third intramuscular injection of DAPTACEL (lot number C2800AA); a second intramuscular injection of FLUZONE No Preservative 2007-2008 ( lot number UT2459LB); a third subcutaneous injection of IPOL (lot number A0169-2); a third intramuscular injection of PREVNAR (Wyeth, lot number C45150); and a third intramuscular injection of PEDVAXHIB (Merck, lot number 0076U).  The following day, the patient fell at home and hit his head, and later presented to the emergency room with a fever.  The following day he presented to the emergency department again with fever (103.1) and upper respiratory infection symptoms including cough, post tussive emesis, and irritability.  It was noted that he had a sick sibling at home.  He was treated with intravenous antibiotics and antipyretics, and discharged to home.  The next day, on 23 February 2008, he was seen by his primary care physician with respiratory congestion, wheezing, and intercostal retractions.  He was admitted to the hospital at that time with additional symptoms of bronchiolitis, conjunctivitis, otitis media, irritability, and poor appetite.  He was initially treated with breathing treatments and intravenous antibiotics.  During the course of his hospitalization he developed a diffuse urticarial rash, inflamed conjunctiva, swelling of the hands and feet, peeling skin on the feet, and red lips.  His fever increased to 106 degrees, and on 28 February 2008 he was transferred to a higher level of care.  Laboratory testing at that time revealed the following:  CRP 273, WBC 26,000, platelets 718,000, SGOT 44; electrolytes and echocardiogram were within limits, and viral testing and blood cultures were negative.  Cardiology was consulted, and he was diagnosed with atypical Kawasaki's disease without evidence of cardiac lesions.  He was treated with intravenous immunoglobulins and aspirin, after which he improved and was discharged to home on 03 March 2008 with instructions to follow-up for serial echocardiograms.  The event was considered to be recovered.
Age: 1.0
Sex: M
Vaccine: DTAP, FLU3, HIBV, IPV, PNC, DTAP, FLU3, HIBV, IPV, PNC
Symptoms: Upper respiratory tract congestion, Upper respiratory tract infection, Urticaria, Use of accessory respiratory muscles, Viral test negative
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 306745).  A one-year-old male patient received the following vaccinations on 20 February 2008: a third intramuscular injection of DAPTACEL (lot number C2800AA); a second intramuscular injection of FLUZONE No Preservative 2007-2008 ( lot number UT2459LB); a third subcutaneous injection of IPOL (lot number A0169-2); a third intramuscular injection of PREVNAR (Wyeth, lot number C45150); and a third intramuscular injection of PEDVAXHIB (Merck, lot number 0076U).  The following day, the patient fell at home and hit his head, and later presented to the emergency room with a fever.  The following day he presented to the emergency department again with fever (103.1) and upper respiratory infection symptoms including cough, post tussive emesis, and irritability.  It was noted that he had a sick sibling at home.  He was treated with intravenous antibiotics and antipyretics, and discharged to home.  The next day, on 23 February 2008, he was seen by his primary care physician with respiratory congestion, wheezing, and intercostal retractions.  He was admitted to the hospital at that time with additional symptoms of bronchiolitis, conjunctivitis, otitis media, irritability, and poor appetite.  He was initially treated with breathing treatments and intravenous antibiotics.  During the course of his hospitalization he developed a diffuse urticarial rash, inflamed conjunctiva, swelling of the hands and feet, peeling skin on the feet, and red lips.  His fever increased to 106 degrees, and on 28 February 2008 he was transferred to a higher level of care.  Laboratory testing at that time revealed the following:  CRP 273, WBC 26,000, platelets 718,000, SGOT 44; electrolytes and echocardiogram were within limits, and viral testing and blood cultures were negative.  Cardiology was consulted, and he was diagnosed with atypical Kawasaki's disease without evidence of cardiac lesions.  He was treated with intravenous immunoglobulins and aspirin, after which he improved and was discharged to home on 03 March 2008 with instructions to follow-up for serial echocardiograms.  The event was considered to be recovered.
Age: 1.0
Sex: M
Vaccine: DTAP, FLU3, HIBV, IPV, PNC, DTAP, FLU3, HIBV, IPV, PNC
Symptoms: Vomiting, Wheezing, White blood cell count increased
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 306745).  A one-year-old male patient received the following vaccinations on 20 February 2008: a third intramuscular injection of DAPTACEL (lot number C2800AA); a second intramuscular injection of FLUZONE No Preservative 2007-2008 ( lot number UT2459LB); a third subcutaneous injection of IPOL (lot number A0169-2); a third intramuscular injection of PREVNAR (Wyeth, lot number C45150); and a third intramuscular injection of PEDVAXHIB (Merck, lot number 0076U).  The following day, the patient fell at home and hit his head, and later presented to the emergency room with a fever.  The following day he presented to the emergency department again with fever (103.1) and upper respiratory infection symptoms including cough, post tussive emesis, and irritability.  It was noted that he had a sick sibling at home.  He was treated with intravenous antibiotics and antipyretics, and discharged to home.  The next day, on 23 February 2008, he was seen by his primary care physician with respiratory congestion, wheezing, and intercostal retractions.  He was admitted to the hospital at that time with additional symptoms of bronchiolitis, conjunctivitis, otitis media, irritability, and poor appetite.  He was initially treated with breathing treatments and intravenous antibiotics.  During the course of his hospitalization he developed a diffuse urticarial rash, inflamed conjunctiva, swelling of the hands and feet, peeling skin on the feet, and red lips.  His fever increased to 106 degrees, and on 28 February 2008 he was transferred to a higher level of care.  Laboratory testing at that time revealed the following:  CRP 273, WBC 26,000, platelets 718,000, SGOT 44; electrolytes and echocardiogram were within limits, and viral testing and blood cultures were negative.  Cardiology was consulted, and he was diagnosed with atypical Kawasaki's disease without evidence of cardiac lesions.  He was treated with intravenous immunoglobulins and aspirin, after which he improved and was discharged to home on 03 March 2008 with instructions to follow-up for serial echocardiograms.  The event was considered to be recovered.
Age: 0.2
Sex: F
Vaccine: DTAP, HIBV, IPV, PNC, RV5
Symptoms: Injection site erythema, Screaming
Clinical narrative: Initial information was received from a health care professional on 03 July 2008. This case is one of a cluster of two patients. A two month old female patient with a past history of GERD received the following vaccinations on 30 June 2008; a right leg intramuscular injection of ActHIB (lot number UF3700AA); a left leg intramuscular injection of Daptacel (lot number C2953ba); and a left leg intramuscular injection of IPOL (lot numb 0281x). Additionally on 02 June 2008 she had received a second dose of Reconbivax HB (lot number 17146. On 30 June 2008, approximately three hours post vaccination, she had redness of her thigh with screaming for at least three hours. The patient recovered from the events. 14 July 2008, a corrective version has been created using the receipt date from the previous version in order to add a statement reflecting that this is a cluster case. Follow up information was received on 11 August 2008 from a health care professional. The patient was treated with TYLENOL and had relief. The screaming lasted for two to three hours. No further information was provided. The physician reported a similar adverse event in another patient. This event has been captured in case number 2008-02193.
Age: 21.0
Sex: F
Vaccine: HPV4
Symptoms: Arthropathy, Burning sensation, Joint stiffness, Joint swelling, Oedema
Clinical narrative: 3 weeks after the first vaccine I had gained 25 pounds in excess fluid on my joints.  I had 3 hours + of morning stiffness, hot and red joints (predomint in my hands, wrists, toes, and ankles)- bilateral swelling.  Severe edema, etc.  I was treated with steroids and passed around as a mystery illness until almost 1 year later, where I was diagnosed with rheumatoid arthritis at the clinic.  I am currently (and have been for a year) taking plaquenil, humira.  I did take methotrexate for about 6 months, but it caused too much nausea.
Age: 21.0
Sex: F
Vaccine: HPV4
Symptoms: Rheumatoid arthritis, Rheumatoid factor increased, Weight increased
Clinical narrative: 3 weeks after the first vaccine I had gained 25 pounds in excess fluid on my joints.  I had 3 hours + of morning stiffness, hot and red joints (predomint in my hands, wrists, toes, and ankles)- bilateral swelling.  Severe edema, etc.  I was treated with steroids and passed around as a mystery illness until almost 1 year later, where I was diagnosed with rheumatoid arthritis at the clinic.  I am currently (and have been for a year) taking plaquenil, humira.  I did take methotrexate for about 6 months, but it caused too much nausea.
Age: 5.0
Sex: F
Vaccine: DTAPHEPBIP, IPV, MMR
Symptoms: Palpitations, Pyrexia
Clinical narrative: A 05-year-old female patient, with pre-existing history of seizure, experienced heart palpitations and fever on 07 August 2008, i.e. the following day after receiving her 4th intramuscular dose of IPOL, batch number Z1069 in the left leg, her 5th intramuscular dose of PEDIARIX, other MFR, batch number AC21B160BA in the  left leg and her 2nd subcutaneous dose of MMR II, other MFR, batch number 167U in the right leg on 06 August 2008. The patient had a 1 brother or sister. She had no illness at time of vaccination and no concomitant medications. The patient had previously received 4 doses of PEDIARIX, other MFR, 1 dose of MMR II, other MFR and 3 doses of IPOL on unspecified dates. No relevant diagnostic test/lab data were performed. The patient's resolved themselves within 24 hours.
Age: 19.0
Sex: F
Vaccine: IPV, TDAP, HEPA, IPV, MMR, TDAP
Symptoms: Erythema, Pain, Pyrexia, Rash, Rash macular
Clinical narrative: Initial report was received on 07 April 2009 from a health care professional who also provided a temporary VAERS E-Report Number (E-28961).  A 19 year old female patient received ADACEL (lot number C3067, lot number 0348X), and HAVIRX (manufacturer GSK, lot number AHAVB285AB) within four weeks prior.  On 05 April 2009 at 08:00 AM the patient experienced painful, red blotchy raised rash on the left upper arm.  The rash extended from the left shoulder to the left elbow.  The patient self treated with BENADRYL, orally.  On 06 April 2009 the patient was seen at a clinic and a localized red, raised, patchy rash measuring 2.5 inches wide by 5.5 inches long to the left deltoid area.  The temperature was 99.6 orally without lymphadenopathy.  The area was warm to touch with intact range of motion to the left arm.  The patient was advised to continue BENADRYL, apply cool compresses to the area, use TYLENOL for discomfort, and return to the clinic in the morning for evaluation.  The patient was reported as recovered.  Follow-up information received on 04 May 2009 from a health care professional.  The lot number for the IPOL was confirmed to be A1229-2, and was amended in the narrative above.  The reporter confirmed the patient had received the MMRII and HAVRIX vaccines on the same day as the ADACEL and IPOL vaccines, which was on 01 April 2009.  After experiencing the adverse events, the patient did not show up for her follow-up appointment with the physician on 17 April 2009.  After several attempts by the physician to reach the patient by phone, the patient called the physician on 13 April 2009 stating that she "was fine" by 12 April 2009 (referring to the above-mentioned adverse events).  No further information is expected.  List of Documents held by Sender:  none.
Age: 19.0
Sex: F
Vaccine: IPV, TDAP, HEPA, IPV, MMR, TDAP
Symptoms: Skin warm, Swelling
Clinical narrative: Initial report was received on 07 April 2009 from a health care professional who also provided a temporary VAERS E-Report Number (E-28961).  A 19 year old female patient received ADACEL (lot number C3067, lot number 0348X), and HAVIRX (manufacturer GSK, lot number AHAVB285AB) within four weeks prior.  On 05 April 2009 at 08:00 AM the patient experienced painful, red blotchy raised rash on the left upper arm.  The rash extended from the left shoulder to the left elbow.  The patient self treated with BENADRYL, orally.  On 06 April 2009 the patient was seen at a clinic and a localized red, raised, patchy rash measuring 2.5 inches wide by 5.5 inches long to the left deltoid area.  The temperature was 99.6 orally without lymphadenopathy.  The area was warm to touch with intact range of motion to the left arm.  The patient was advised to continue BENADRYL, apply cool compresses to the area, use TYLENOL for discomfort, and return to the clinic in the morning for evaluation.  The patient was reported as recovered.  Follow-up information received on 04 May 2009 from a health care professional.  The lot number for the IPOL was confirmed to be A1229-2, and was amended in the narrative above.  The reporter confirmed the patient had received the MMRII and HAVRIX vaccines on the same day as the ADACEL and IPOL vaccines, which was on 01 April 2009.  After experiencing the adverse events, the patient did not show up for her follow-up appointment with the physician on 17 April 2009.  After several attempts by the physician to reach the patient by phone, the patient called the physician on 13 April 2009 stating that she "was fine" by 12 April 2009 (referring to the above-mentioned adverse events).  No further information is expected.  List of Documents held by Sender:  none.
Age: 19.0
Sex: F
Vaccine: IPV, TDAP, HEPA, IPV, MMR, TDAP
Symptoms: Pain, Pyrexia, Rash erythematous, Rash macular, Skin warm
Clinical narrative: Initial report was received on 07 April 2009 from a health care professional who also provided a temporary VAERS E-Report Number (E-28961).  A 19 year old female patient received ADACEL (lot number C3067, lot number 0348X), and HAVIRX (manufacturer GSK, lot number AHAVB285AB) within four weeks prior.  On 05 April 2009 at 08:00 AM the patient experienced painful, red blotchy raised rash on the left upper arm.  The rash extended from the left shoulder to the left elbow.  The patient self treated with BENADRYL, orally.  On 06 April 2009 the patient was seen at a clinic and a localized red, raised, patchy rash measuring 2.5 inches wide by 5.5 inches long to the left deltoid area.  The temperature was 99.6 orally without lymphadenopathy.  The area was warm to touch with intact range of motion to the left arm.  The patient was advised to continue BENADRYL, apply cool compresses to the area, use TYLENOL for discomfort, and return to the clinic in the morning for evaluation.  The patient was reported as recovered.  Follow-up information received on 04 May 2009 from a health care professional.  The lot number for the IPOL was confirmed to be A1229-2, and was amended in the narrative above.  The reporter confirmed the patient had received the MMRII and HAVRIX vaccines on the same day as the ADACEL and IPOL vaccines, which was on 01 April 2009.  After experiencing the adverse events, the patient did not show up for her follow-up appointment with the physician on 17 April 2009.  After several attempts by the physician to reach the patient by phone, the patient called the physician on 13 April 2009 stating that she "was fine" by 12 April 2009 (referring to the above-mentioned adverse events).  No further information is expected.  List of Documents held by Sender:  none.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, DTAP, IPV, DTAP, IPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: This non serious case was received on 28 April 2009 from a health care professional.  A four year old male patient received IPOL intramuscularly in the left deltoid (lot number B0475-2) and INFANRIX intramuscularly in the left deltoid (lot number AC14B066A) on 24 April 2009 at 9:00 AM.  At 3:00 PM the patient developed injection site swelling the size of a softball, redness, tender to touch, hard to touch from the elbow to the shoulder.  The patient also had a low grade temperature of 100.1.  The physician recommended MOTRIN and BENADRYL for 48 hours.  At the time of the report the patient was improving.  Follow-up information received on 12 May 2009 from a health care professional.  The patient weighed 8 pounds 11 ounces at birth, and he has one brother, and one half brothers.  The patient had no concurrent illnesses, or use of other medications at the time of the vaccination on 24 April 2009.  The patient had received three doses of PEDIARIX prior to 24 April 2009; however the vaccination dates were not reported and it was not reported whether the patient had experienced any adverse events with those doses.  The IPOL vaccine administered on 24 April 2009 was the fourth dose of polio vaccine received.  The patient recovered on 29 April 2009 with no evidence of immunization reaction.  No further information is expected.  List of Documents held by Sender:  none.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, DTAP, IPV, DTAP, IPV
Symptoms: Body temperature increased, Feeling hot, Injection site erythema, Injection site induration, Injection site pain
Clinical narrative: This non serious case was received on 28 April 2009 from a health care professional.  A four year old male patient received IPOL intramuscularly in the left deltoid (lot number B0475-2) and INFANRIX intramuscularly in the left deltoid (lot number AC14B066A) on 24 April 2009 at 9:00 AM.  At 3:00 PM the patient developed injection site swelling the size of a softball, redness, tender to touch, hard to touch from the elbow to the shoulder.  The patient also had a low grade temperature of 100.1.  The physician recommended MOTRIN and BENADRYL for 48 hours.  At the time of the report the patient was improving.  Follow-up information received on 12 May 2009 from a health care professional.  The patient weighed 8 pounds 11 ounces at birth, and he has one brother, and one half brothers.  The patient had no concurrent illnesses, or use of other medications at the time of the vaccination on 24 April 2009.  The patient had received three doses of PEDIARIX prior to 24 April 2009; however the vaccination dates were not reported and it was not reported whether the patient had experienced any adverse events with those doses.  The IPOL vaccine administered on 24 April 2009 was the fourth dose of polio vaccine received.  The patient recovered on 29 April 2009 with no evidence of immunization reaction.  No further information is expected.  List of Documents held by Sender:  none.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, DTAP, IPV, DTAP, IPV
Symptoms: Injection site swelling, Injection site warmth, Pyrexia
Clinical narrative: This non serious case was received on 28 April 2009 from a health care professional.  A four year old male patient received IPOL intramuscularly in the left deltoid (lot number B0475-2) and INFANRIX intramuscularly in the left deltoid (lot number AC14B066A) on 24 April 2009 at 9:00 AM.  At 3:00 PM the patient developed injection site swelling the size of a softball, redness, tender to touch, hard to touch from the elbow to the shoulder.  The patient also had a low grade temperature of 100.1.  The physician recommended MOTRIN and BENADRYL for 48 hours.  At the time of the report the patient was improving.  Follow-up information received on 12 May 2009 from a health care professional.  The patient weighed 8 pounds 11 ounces at birth, and he has one brother, and one half brothers.  The patient had no concurrent illnesses, or use of other medications at the time of the vaccination on 24 April 2009.  The patient had received three doses of PEDIARIX prior to 24 April 2009; however the vaccination dates were not reported and it was not reported whether the patient had experienced any adverse events with those doses.  The IPOL vaccine administered on 24 April 2009 was the fourth dose of polio vaccine received.  The patient recovered on 29 April 2009 with no evidence of immunization reaction.  No further information is expected.  List of Documents held by Sender:  none.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, DTAP, IPV, DTAP, IPV
Symptoms: Induration, Injection site erythema, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: This non serious case was received on 28 April 2009 from a health care professional.  A four year old male patient received IPOL intramuscularly in the left deltoid (lot number B0475-2) and INFANRIX intramuscularly in the left deltoid (lot number AC14B066A) on 24 April 2009 at 9:00 AM.  At 3:00 PM the patient developed injection site swelling the size of a softball, redness, tender to touch, hard to touch from the elbow to the shoulder.  The patient also had a low grade temperature of 100.1.  The physician recommended MOTRIN and BENADRYL for 48 hours.  At the time of the report the patient was improving.  Follow-up information received on 12 May 2009 from a health care professional.  The patient weighed 8 pounds 11 ounces at birth, and he has one brother, and one half brothers.  The patient had no concurrent illnesses, or use of other medications at the time of the vaccination on 24 April 2009.  The patient had received three doses of PEDIARIX prior to 24 April 2009; however the vaccination dates were not reported and it was not reported whether the patient had experienced any adverse events with those doses.  The IPOL vaccine administered on 24 April 2009 was the fourth dose of polio vaccine received.  The patient recovered on 29 April 2009 with no evidence of immunization reaction.  No further information is expected.  List of Documents held by Sender:  none.
Age: 0.2
Sex: F
Vaccine: DTAPIPVHIB, HIBV, PNC, RV5, RV5
Symptoms: Culture stool negative, Diarrhoea, Occult blood, Occult blood positive, White blood cells stool positive
Clinical narrative: Information has been received from a physician concerning a 9 week old female who on 08-MAY-2009 was vaccinated orally with her first dose of ROTATEQ (lot number 663711/0107Y). The physician reported that the patient "experienced multiple cases of diarrhea after receiving her first dose of ROTATEQ". The patient was not tested for rotavirus so it was unknown if this was the cause of the diarrhea". The patient recovered from multiple cases of diarrhea within an unspecified time. The patient sought unspecified medical attention. Follow-up information has been received from a health professional concerning the patient with no relevant medical history. It was reported that in the morning of 22-APR-2009 (previously reported as 08-MAY-2009) the patient was vaccinated orally with the first dose of ROTATEQ (lot number 663711/0107Y). There was no illness at the time of vaccination. On 25-APR-2009 at 10:00 am, the patient presented with increased stools which had increased odor and were mucousy. It was reported that the patient had blood in up to 10 stools per day. On an unspecified date, stool cultures were done guaic were positive x2, and rotavirus antigen and Yersinia were sent (results were not reported). The symptoms persisted during 3 weeks and in May 2009 the patient recovered. Upon internal review blood in up to 10 stools per day was considered to be another important medical event. No further information is available.
Age: 0.2
Sex: F
Vaccine: DTAPIPVHIB, HIBV, PNC, RV5, RV5
Symptoms: Abnormal faeces, Diarrhoea, Frequent bowel movements, Haematochezia, Mucous stools
Clinical narrative: Information has been received from a physician concerning a 9 week old female who on 08-MAY-2009 was vaccinated orally with her first dose of ROTATEQ (lot number 663711/0107Y). The physician reported that the patient "experienced multiple cases of diarrhea after receiving her first dose of ROTATEQ". The patient was not tested for rotavirus so it was unknown if this was the cause of the diarrhea". The patient recovered from multiple cases of diarrhea within an unspecified time. The patient sought unspecified medical attention. Follow-up information has been received from a health professional concerning the patient with no relevant medical history. It was reported that in the morning of 22-APR-2009 (previously reported as 08-MAY-2009) the patient was vaccinated orally with the first dose of ROTATEQ (lot number 663711/0107Y). There was no illness at the time of vaccination. On 25-APR-2009 at 10:00 am, the patient presented with increased stools which had increased odor and were mucousy. It was reported that the patient had blood in up to 10 stools per day. On an unspecified date, stool cultures were done guaic were positive x2, and rotavirus antigen and Yersinia were sent (results were not reported). The symptoms persisted during 3 weeks and in May 2009 the patient recovered. Upon internal review blood in up to 10 stools per day was considered to be another important medical event. No further information is available.
Age: 0.2
Sex: F
Vaccine: DTAPIPVHIB, HIBV, PNC, RV5, RV5
Symptoms: Rotavirus test positive, Yersinia serology positive
Clinical narrative: Information has been received from a physician concerning a 9 week old female who on 08-MAY-2009 was vaccinated orally with her first dose of ROTATEQ (lot number 663711/0107Y). The physician reported that the patient "experienced multiple cases of diarrhea after receiving her first dose of ROTATEQ". The patient was not tested for rotavirus so it was unknown if this was the cause of the diarrhea". The patient recovered from multiple cases of diarrhea within an unspecified time. The patient sought unspecified medical attention. Follow-up information has been received from a health professional concerning the patient with no relevant medical history. It was reported that in the morning of 22-APR-2009 (previously reported as 08-MAY-2009) the patient was vaccinated orally with the first dose of ROTATEQ (lot number 663711/0107Y). There was no illness at the time of vaccination. On 25-APR-2009 at 10:00 am, the patient presented with increased stools which had increased odor and were mucousy. It was reported that the patient had blood in up to 10 stools per day. On an unspecified date, stool cultures were done guaic were positive x2, and rotavirus antigen and Yersinia were sent (results were not reported). The symptoms persisted during 3 weeks and in May 2009 the patient recovered. Upon internal review blood in up to 10 stools per day was considered to be another important medical event. No further information is available.
Age: 63.0
Sex: M
Vaccine: FLU3
Symptoms: Cardiac failure, Death, Hypoaesthesia, Intensive care, Mobility decreased
Clinical narrative: On 10-01-08 he complained of soreness and unusual weakness and numbness in legs (after physical therapy).  Had to have help to & from wheelchair and bed.  Much worse Thur, Fri.  By Sat. he could not move on his own from chest down.  Convinced him to go to ER on Sunday.  Paralyzed by PM 10-05-08.  Transferred to hospital 10-05-08, put in ICU AM 10-06-08.  Code blue (heart failure 10-10-08).  See med. reports (Also I kept diary) too numerous.  9/11/09 Hospital records received DOS 10/6/08 to 10/21/08. Assessment: Cardiorespiratory failure. Advanced Guillain-Barre Syndrome. Chronic renal disease with initiation of hemodialysis. Type 2 Diabetes Mellitus with increased rhabdomyolysis. Episode of supraventricular tachycardia. Episode of cardiac arrhythmia. Probable sepsis.   Patient transfered to facility after noticing weakness in upper and lower extremity. Plasmapheresus. Renal functioning worsened. Flaccid. Pneumonia. Extubated per patient's desire. Quickly expired.  10/5/09 Death Cert received with COD=Cardiorespiratory Failure due to End Stage Renal Disease due to Guillain-Barre Syndrome
Age: 63.0
Sex: M
Vaccine: FLU3
Symptoms: Muscular weakness, Pain in extremity, Paralysis, Wheelchair user
Clinical narrative: On 10-01-08 he complained of soreness and unusual weakness and numbness in legs (after physical therapy).  Had to have help to & from wheelchair and bed.  Much worse Thur, Fri.  By Sat. he could not move on his own from chest down.  Convinced him to go to ER on Sunday.  Paralyzed by PM 10-05-08.  Transferred to hospital 10-05-08, put in ICU AM 10-06-08.  Code blue (heart failure 10-10-08).  See med. reports (Also I kept diary) too numerous.  9/11/09 Hospital records received DOS 10/6/08 to 10/21/08. Assessment: Cardiorespiratory failure. Advanced Guillain-Barre Syndrome. Chronic renal disease with initiation of hemodialysis. Type 2 Diabetes Mellitus with increased rhabdomyolysis. Episode of supraventricular tachycardia. Episode of cardiac arrhythmia. Probable sepsis.   Patient transfered to facility after noticing weakness in upper and lower extremity. Plasmapheresus. Renal functioning worsened. Flaccid. Pneumonia. Extubated per patient's desire. Quickly expired.  10/5/09 Death Cert received with COD=Cardiorespiratory Failure due to End Stage Renal Disease due to Guillain-Barre Syndrome
Age: 85.0
Sex: F
Vaccine: VARZOS
Symptoms: Condition aggravated, Oral herpes
Clinical narrative: Shortly after vaccinated: broke out of cold sores in places on the face where 2 had before had a cold sore. Have had 3 outbreaks in nostrils (nose).
Age: 5.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Agitation, Sleep terror
Clinical narrative: Night tremors; upset agitated; not quite awake. 1-2x/night.
Age: 19.0
Sex: M
Vaccine: SMALL
Symptoms: Erythema, Rash, Vaccination complication
Clinical narrative: Pt vaccinated smallpox 8/8/09; left arm. Pt referred to clinic with POS erythema and rash with circumfererencial distribution to torso, arms, thighs and feet. Dx adverse vaccine reaction. Pt treated with BENADRYL and ADARAX. Will f/u if condition worsens.
Age: 4.0
Sex: F
Vaccine: DTAPIPVHIB, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Swelling of arm at injection site with warmth and erythema. Injected arm 7.5 cm larger than non injected arm 18.5 cm vs 25 cm arm circumference.
Age: 1.0
Sex: M
Vaccine: DTAPIPVHIB, MMR, PNC, VARCEL
Symptoms: Differential white blood cell count normal, Full blood count normal, Pyrexia
Clinical narrative: Had fever for 1st 2 sets of shots for 48 hrs including his single PREVNAR vaccine #3.  With last set #4 he ran fever for 7 days 102 & greater.  He did not run fever with 3rd set of shot (no PREVNAR).  We were on back order.
Age: 1.3
Sex: F
Vaccine: HIBV, PNC
Symptoms: Injection site erythema, Injection site pain, Pyrexia
Clinical narrative: Shot RXN left thigh red, sore, fever.
Age: 1.0
Sex: F
Vaccine: HEP, PNC
Symptoms: Decreased appetite, Irritability, Movement disorder, Pyrexia, Rash
Clinical narrative: Within 48 hours: High fever, irritability, drowsiness, loss of appetite, rash (Fever 102.3 Tmax). For 72 hours: Interference with limb movement (shaky walking only after 48 hours).